Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients

Neurobiology of Disease

Volumn 7, Issue 6, 2000, Pages 600-612

  Feigenbaum, Valérie ^a   Gélot, Antoinette ^b   Casanova, Philippe ^a   Daumas Duport, Catherine ^c   Aubourg, Patrick ^d   Dubois Dalcq, Monique ^a  

^a INSTITUT PASTEUR   (France)

^b CEA   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3;

ADRENOLEUKODYSTROPHY; ADULT; APOPTOSIS; ARTICLE; AUTOPSY; BRAIN STEM; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHILD; CONTROLLED STUDY; DEMYELINATION; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NICK END LABELING; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; TELENCEPHALON; WHITE MATTER;

EID: 0034523144     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0315     Document Type: Article

References (50)

1. Neuronal apoptosis in HIV infection in adults
2. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy
3. Human ICE/CED-3 protease nomenclature
4. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
5. Apoptosis. The role of endonuclease
6. The X-linked Adrenoleukodystrophy Enigma: How does the ALD peroxisomal transporter mutation affect CNS glia?
7. X-linked adrenoleukodystrophy
8. Cell death and control of cell survival in the oligodendrocyte lineage
9. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis
10. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity
11. Multiple sclerosis: Fas signaling in oligodendrocyte cell death
12. The role of apoptosis in neurodegenerative diseases
13. Cell death and birth in multiple sclerosis brain
14. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
15. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice
16. Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system
17. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
18. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation
19. Neuropathology of early HIV-1 infection
20. Oligodendrocyte apoptosis mediated by caspase activation
21. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy
22. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism
23. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease
24. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions
25. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
26. TUNEL apoptotic cell detection in tissue sections: Critical evaluation and improvement critical evaluation and improvement
27. Homo- and heterodimerization of peroxisomal ATP-binding cassette (ABC) half-transporters
28. A mouse model for X-linked adrenoleukodystrophy
29. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis
30. Preventing neurodegeneration in the Drosophila mutant bubblegum
31. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy
32. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
33. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
34. Caspases: Killer proteases
35. Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes
36. The inflammatory myelinopathy of adreno-leukodystrophy: Cells, effector molecules, and pathogenetic implications
37. Cell suicide for beginners
38. Cyclic AMP regulates the rate of differentiation of oligodendrocytes without changing the lineage commitment of their progenitors
39. Adrenoleukodystrophy. A clinical and pathological study of 17 cases
40. Classification and biology of astrocytic gliomas
41. Role of very-long-chain acyl-coenzyme A synthetase in X-linked adrenoleukodystrophy
42. Properties of the caspases
43. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter
44. Differentiation and death of premyelinating Oligodendrocytes in developing rodent brain
45. Detection of activated caspase-3 (CPP32) in the vertebrate nervous system during development by a cleavage site-directed antiserum
46. Patterns of cell death
47. Detection of the initial stages of DNA fragmentation in apoptosis
48. In vitro evidence for a dual role of TNF-alpha in human immunodeficiency virus type 1 encephalopathy
49. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
50. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis